Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL

Clinical trial NCT03212807 · WITHDRAWN

Trial details

NCT number: NCT03212807
Sponsor: Singapore General Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

EBV Related Non-Hodgkin's Lymphoma Primary CNS Lymphoma Primary Testicular Lymphoma

Start date: 2017-08-01
Primary completion: 2021-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.